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Background: Bovine Spastic Paresis (BSP) is a neuromuscular disorder which affects both male and female cattle.
BSP is characterized by spastic contraction and overextension of the gastrocnemious muscle of one or both limbs
and is associated with a scarce increase in body weight. This disease seems to be caused by an autosomal and
recessive gene, with incomplete penetration, although no genes clearly involved with its onset have been so far
identified. We employed cDNA microarrays to identify metabolic pathways affected by BSP in Romagnola cattle
breed. Investigation of those pathways at the genome level can help to understand this disease.
Results: Microarray analysis of control and affected individuals resulted in 268 differentially expressed genes. These
genes were subjected to KEGG pathway functional clustering analysis, revealing that they are predominantly
involved in Cell Communication, Signalling Molecules and Interaction and Signal Transduction, Diseases and
Nervous System classes. Significantly enriched KEGG pathway’s classes for the differentially expressed genes were
calculated; interestingly, all those significantly under-expressed in the affected samples are included in
Neurodegenerative Diseases. To identify genome locations possibly harbouring gene(s) involved in the disease, the
chromosome distribution of the differentially expressed genes was also investigated.
Conclusions: The cDNA microarray we used in this study contains a brain library and, even if carrying an
incomplete transcriptome representation, it has proven to be a valuable tool allowing us to add useful and new
information to a poorly studied disease. By using this tool, we examined nearly 15000 transcripts and analysed
gene pathways affected by the disease. Particularly, our data suggest also a defective glycinergic synaptic
transmission in the development of the disease and an alteration of calcium signalling proteins. We provide data to
acquire knowledge of a genetic disease for which literature still presents poor results and that could be further and
specifically analysed in the next future. Moreover this study, performed in livestock, may also harbour molecular
information useful for understanding human diseases.Background
The Bovine Spastic Paresis (BSP) is a neuromuscular dis-
order known since the twenties of past century, affecting
both males and females. BSP is characterized by an over-
extension of the gastrocnemious muscle and linked to a
scarce increase in body weight [1]. Although the genes
involved have not been identified so far, the current hy-
pothesis is that the disease is due a single autosomal reces-
sive mutation with incomplete penetrance [2]. The BSP
symptoms are similar to those of human hyperekplexia* Correspondence: alessio@unitus.it
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reproduction in any medium, provided the or(OMIM ID #149400), a disease caused by mutations in
genes encoding glycinergic proteins (GLRA1, OMIM ID
#138491; SLC6A5, OMIM ID # 604159; GLRB, OMIM ID
#138492; GPHN, OMIM ID #603930; ARHGEF9, OMIM
ID #300429). Besides the economic importance in agricul-
ture, BSP may therefore constitute a model also for the
human disease.
We studied BSP in Romagnola cattle breed, which pre-
sents the disease with a frequency of 0.6% [2]. Since BSP
is reported to be associated to the nervous system [3,4],
we performed a microarray analysis on cDNA obtained
from spinal cord of normal and affected cattle, in order
to identify metabolic pathways associated with the dis-
ease. The aim of this study was to detect variations inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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healthy and affected animals and to spot genome regions
where genes responsible for the disease are more likely
to map. This can help in pinpointing a number of genes
potentially involved in the disease, providing suitable
data for a future gene scan approach.
Methods
Samples
Samples of spinal cord of affected and control individ-
uals of Romagnola breed, males and females, were col-
lected from C6 to L6 immediately after slaughtering and
later stored in RNA (Sigma-Aldrich). We expected to
find most of the genes involved in the spinal cord, being
the disease linked to the nervous system [3,4]. The ex-
perimental work was approved by the Animal Ethics
Committee of CRA, Italy, in accordance with local eth-
ical requirements. Total RNA was extracted from 250 μg
tissue samples by homogenization in QIAzolLysis Re-
agent (Qiagen) and according to RNeasy Lipid kit
(Qiagen) protocol. After purification, RNA integrity was
determined spectroscopically (GeneQuantpro, Amersham
Pharmacia Biotech) and by gel electrophoresis. Only RNA
with A260/280 and A260/230 ratios above 1.8 was used
for amplification. RNA was quantified using a DTX 800
Multimode Detector (Beckman Coulter) using quant-it kit
(Invitrogen). For microarray analysis, RNA aliquots of 4
controls and 4 affected samples were pooled to reduce the
template needed and to exclude differences in expression
due to individual variation and not related to BSP [5]. For
qRT-PCR, individual RNA samples from the same animal
and tissue samples were quantified as described above and
used for the amplification.
Microarray experiments
Microarray slides, containing about 15 k cDNA repli-
cated twice, were obtained by ARK genomics (The
Roslin Institute & R(D)SVS, University of Edinburgh,
Scotland). They were chosen for containing spots from a
bovine brain library [6], a bovine monocyte library [7]
and 979 control spots (landing lights, blank, salmon
sperm, housekeeping genes). As stated in the previous
section, the disease is likely to be linked to the nervous
system [3,4]. Within each slide all spots are printed in
duplicate; the experiment included two technical repli-
cates; in each replicate two slides were duplicated in a
dye-swap experiment [8]. We subsequently obtained a
total of 8 replicates per cDNA spot. Inverse transcription
was realized by SuperScript Indirect cDNA Labelling
System (Invitrogen). Fluorescently-labeledcRNA was
prepared using the 3DNA Array 900 MPX Cy3/Cy5 Kit
(Genisphere), according to the manufacturer’s protocol.
Pooled cDNA probes of 4 control and 4 affected animals
were hybridised onto each bovine cDNA slide, accordingto Genisphere’s instructions. In short, 2 μg of total RNA
was reverse transcribed using RT dT primer. Then, the
cDNA and the fluorescent 3DNA reagent were hybrid-
ized to the microarray in succession. The fluorescent
3DNA reagent (Cy3 and Cy5) hybridize to the cDNA by
a “capture sequence” complementary to a sequence on
the 5’ end of the RT primer. Hybridization was
performed at 60°C for 16 hours in a hybridization oven
with shaking. Upon hybridization, microarrays were
washed and dried according to the Genisphere’s instruc-
tions and fluorescence measurements were performed
using a ScanArrayLite (Perkin Elmer) laser scanner.
Quantitative real time PCR
RNA from the same animal and tissue samples were
used to validate the microarray data. 1 μg of total RNA
from affected and control samples was reverse tran-
scribed into cDNA using a blend of oligo-dT and ran-
dom hexanucleotides and the QuantiscriptReverse
Transcriptase (Quiagen). cDNA was transcribed in
pools, using two control and two affected samples. Be-
fore making the qRT-PCR, a PCR was performed on all
cDNA samples to assess the quality of the cDNA. A
standard curve was generated using serial dilutions of
the cDNA to calculate the efficiency of amplification.
Real-time quantitative PCR was set up for three genes
(ATP6V01, S100A12 and BCL2L1). Primer pairs, designed
using primer3 [9], are listed in Additional file 1: Table S1
and are derived from publically available bovine ESTs.
qRT-PCR was performed with the Brilliant II SYBR Green
qRT-PCR kit (Stratagene, Agilent technologies) and using
a Stratagene Mx3005P (Stratagene). Amplification results
of affected samples were calibrated against those of
controls to obtain the differences in gene expression.
All results were normalized to ß-actin. Three bio-
logical replicates and two technical replicates were
performed for each gene investigated.
Polymerase chain reaction (PCR) conditions and sequence
analysis
PCR primers for ATP2A1/SERCA and SLC6A5 (Additional
file 1: Table S1) were designed using primer3 [9] from the
sequences available in Genbank (ATP2A1 NC_007326.4;
SLC6A5 NC_007330.4) to amplify genomic fragments in-
cluding mutations in the exons 6 and 16 for ATP2A1 and
in exons 3 and 4 for SLC6A5. Each polymerase chain reac-
tion (PCR) was performed in a total volume of 20 μl
containing 20 ng of genomic DNA, 1.0 pMol of each pri-
mer, 10 μl of BioMix (Bioline) composed by BIOTAQDNA
Polymerase and 2 mM of dNTPs, on a PTC-100TM Peltier
Thermal Cycler (MJ Research). A 5 minutes denaturation
step was followed by 34 cycles of denaturation at 94°C
(30 sec), annealing at 59°C (30 sec) and extension at 72°C
(1 min); the final extension step was carried out at 72°C for
Table 1 Comparison of microarray and qRT-PCR results
Gene Microarray qRT-PCR
FC P value FC P value
BCL2L1 2.34 0.0377 10.24 0.00017
S100A12 23.71 0.0055 15.76 0.00022
ATP6V01 81.29 0.0008 6.30 0.01775
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(USB Corporation) to remove residual primers and dNTPs
and used as templates for forward and reverse sequencing
reactions. Sequencing was performed using a ceq8800 se-
quencer using DTCS QuickStart Kit and purifying with
AgencourtCleanSEQ 96 (Beckman Coulter), according to
manufacturer instructions. Sequences were aligned with
Bioedit software [10].
Data analysis
Images were obtained by a ScanArrayLite (Perkin Elmer)
laser scanner using Spotfinder software (TIGR). cDNA
spots were automatically segmented, total foreground
and background intensities of the two dyes were calcu-
lated for each spot. The spots were flagged by the soft-
ware when they exhibited poor hybridization signals or
when they were saturated. Spots with signal to back-
ground ratio below 1.5 were filtered out, together with
flagged spots. Data systematic bias was removed by ap-
plying the dye-swap normalization [8,11] that uses the
reverse labelling in the microarray replicates and the
lowness normalization [12,13]. The subtraction of the
local spot background signal from the foreground signal
was done according to the method developed by Scharpf
and coauthors [14]. To establish the significance of the
differential expression for each probe the t-test, was
used, correcting p-values for multiple tests [15]. Finally,
only genes with absolute value of the fold change at least
2.0 and a p-value < 0.05 were considered.
KEGG pathways were retrieved for all slide genes [16-18].
Real Time data were analysed using the accompanying
MxPro software (Stratagene). Relative expression of each
gene for each sample was calculated by comparing Ct
values of the target gene with Ct values of the ß-actin
constitutive gene product. T-test was performed in order
to assess the statistical significance of the RT-PCR
results.
Functional analysis
Functional analysis of gene lists was performed using the
set of web-based functional annotation tools DAVID
v6.7 [19,20]. The clustering tool was first used to check
slide genes coverage and then to compare DEG path-
ways with the genes spotted on the slide. Furthermore
hypergeometric test was computed to compare distribu-
tion in C1 class of KEGG pathways with genes spotted
on slide. Then, DAVID tool was used to look for func-
tional enrichment for genes over- and under-expressed
more than two-fold in our samples. The statistical sig-
nificance of the enrichment for the KEGG pathways of
interest was computed by DAVID using the Fisher Exact
test. KEGG pathway was selected as the functional anno-
tation category for these analysis, assuming minimum
number of genes for the corresponding C3 term (CountThreshold) = 2 and maximum EASE Score (modified
Fisher P-value Threshold) = 0.005 for enrichment ana-




To identify genes possibly involved in BSP development,
we performed an experiment using a bovine cDNA
microarray by hybridising cDNA of affected and control
Romagnola samples. Differentially Expressed Genes
(DEGs) were identified using t-test statistics. A p-value
<0.05, corrected for multiple tests, and an absolute Fold
Change value (|FC|) ≥2.0 were used as criteria for the
identification of DEGs. After filtering, 268 genes were
found significantly over/under expressed in affected ani-
mals versus healthy controls; DEGs were annotated on
Btau_4.0 version of the bovine genome, see Additional
file 2: Table S2. The search in genomic databases was re-
peated several times during manuscript preparation to
include sequences recently added in NCBI. The data
have been deposited in NCBI Gene Expression Omnibus
(GEO, http://www.ncbi.nlm.nih.gov/geo/info/linking.html)
and are accessible through GEO, series accession number
GSE25243. To validate microarray results, the expression
of three genes (ATP6V01, S100A12 and BCL2L1), signifi-
cantly over-expressed in affected samples, were tested by
Quantitative Real Time PCR (qRT-PCR). The qRT-PCR
data confirmed that the genes were significantly over-
expressed in affected with respect to control samples
(Table 1).
In the affected samples we observed a over-expression
of the following genes: ATP6V0E1 which is involved in
Oxidative Phosphorylatin pathway (FC 81.25); CATHL1
(FC 21.65) which is linked to Organismal Systems and
Infectious Diseases pathway; the calcium binding protein
S100A12 (FC 23.71) which is involved in the Calcium
Signalling pathway; the HIST2H2AC (FC 5.90) which is
involved in the Immune System Disease class; and the
ATP/GTP binding protein-like gene AGBL5 (FC 3.67).
Under-expression in affected samples was less marked
(minimum value of FC -3.3). Among the under-expressed
genes we observed the chromatin regulator SMARCA5
(FC -2.92); the transcription factor CREBZF (FC -2.83).
The Rho GDP dissociation inhibitor (GDI) alpha
(ARHGDIA) is under-expressed in affected samples
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FC 2.361; SLC25A20, FC -2.191) and one organic anion trans-
porter of the solute carrier family (SLCO1A2, FC -2.414)
resulted altered in affected animals. Moreover, in affected
samples we observed the over-expression of GRINA (FC
1.97) and SLC6A9 (FC 1.9), two genes involved in
glycinergic synaptic transmission. The GFAP gene, encod-
ing for the glial fibrillary acidic protein, was also over-
expressed in affected animals (FC 2.60). The NR4A2 (FC
3.06) gene, a nuclear receptor family protein associated
with dopaminergic dysfunctions, was over-expressed in af-
fected animals.
We investigated the distribution of the DEGs in the
bovine genome (UMD3.1 version). All Bos taurus chro-
mosomes (BTAs) harbour differentially expressed genes;
and a 30% percentage of them, is found in chromosomes
2, 3, 5, 7 and 18. We found over- and under-expressed
gene clusters in narrow regions on BTA3, BTA5, BTA18
BTA21 and BTA22. Anyway, we have computed the χ2
statistics and we have not found any significant cluster-
ing of DEGs in these specific regions.
Gene expression and KEGG analysis
The Kyoto Encyclopedia of Genes and Genomes (KEGG)
database was used to link microarray results to KEGG
pathways to their relative C1, C2 and C3 classes
(Table 2). Of the 268 DEGs in the microarray experi-
ment, 195 were annotated sequences, linked to KEGG
pathways and to their relative classes; 29 represented un-
identified transcripts and 22 encoded for proteins with
poorly known or unknown function. The NCBI web-
based functional annotation tool DAVID v. 6.7 (Database
for Annotation, Visualization and Integrated Discovery)
was used to investigate functional associations of geneTable 2 Significantly enriched KEGG pathway’s classes for the
86 genes with under-expressed expression in affected anima
threshold = 0.05)
C1 class C2 class C
over-expressed
Cellular Processes Cell Communication F
Human Diseases Cancers P














Human Diseases Cancers C
le
under-expressed Human Diseases Neurodegenerative
Diseases
A
sexpression changes among differentially expressed
genes [21].
This clustering tool was first used to check if all the
spotted genes from the libraries were uniformly
scattered across functional classes, showing a good rep-
resentation of KEGG Pathways C1 class distribution.
The frequency of all genes on the slide and of DEGs
(Figure 1) showed that, in KEGG C1 class, the two dis-
tributions are significantly independent (P < 0.001).
DAVID was used to analyse genes more than two-fold
over- and under-expressed in our samples. Significant
functional clustering of affected animals versus healthy
controls in KEGG pathways is presented in Table 2. The
109 over-expressed genes belong to Cell Communica-
tion, Signaling Molecules and Interaction, Signal Trans-
duction, Cancers and Nervous System C2 classes.
Among the 86 genes under-expressed, the Neurodegen-
erative Diseases KEGG pathway C2 class results the only
significant pathway in affected samples.
Two interesting C3 classes, the Amyotrophic Lateral
Sclerosis (ALS) and the Neurotrophin signalling pathway
are significantly enriched (see Functional analysis in
Methods). The Amyotrophic Lateral Sclerosis belongs to
the C2 class of Neurodegenerative Diseases and includes
the under-expressed genes DERL1, NEFH and NEFL.
The significant genes belonging to the Neurotrophin sig-
nalling pathway (a C2 class of Nervous System) are
AKT2, ATF4, BAD, CAMK2A and SH2B3. In addition,
we observed under expression of NDUFB2 (FC -2.24)
and TRAPPC4 (FC -2.82) genes which have a role in
postsynaptic membrane trafficking and are differentially
expressed in Parkinson’s disease pathway [22]. The BAD,
NEFH, NEFL and DERL1 genes are also involved in
Huntington’s disease pathways. The Amyotrophic Lateral109 genes with over-expressed expression and for the
ls versus healthy controls (Count threshold =2, EASE
3 class Genes p-value
ocal adhesion LOC518180, COL4A2, COL1A2,
PRKCG, LAMC2, BAD, THBS1, AKT2
0.0005
athways in cancer LOC518180, DVL2, COL4A2, PRKCG,



















LOC518180, BCL2L1, BAD, AKT2 0.020
myotrophic lateral
clerosis (ALS)
DERL1, NEFH, NEFL 0.016
Figure 1 Gene clusters. Comparison of clustering between the 195 over- or under-expressed DEGs (|FC| ≥ 2) and the annotated genes on the
slide, was assessed using the NCBI DAVID tool. C1 Class KEGG Pathway was selected as the annotation category for clustering.
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pathway pathologies present symptoms partially resem-
bling to BSP’s ones.ATP2A1/SERCA1 and SLC65 variants causative of BSP in
some cattle breeds are not involved in Romagnola BSP
Recently, two genes were associated to other cattle dis-
eases quite similar to spastic paresis: the ATP2A1/
SERCA1 gene which encodes for a calcium-transporting
ATPase and the SLC6A5 gene which encodes a pre-
synaptic glycine transporter. In Belgian Blue and in
Chianina cattle breeds, the ATP2A1/SERCA1 gene was
found to be implicated in the Congenital Muscular Dys-
tonia 1 (CMD1, a disorder of muscle function caused by
defects in the Ca2+ pump) and in the Congenital
Pseudomyotonia [23-26]; while the SLC6A5 gene was
found to be linked to the Congenital Muscular Dystonia
2 (CMD2) [23]. Since in the cDNA microarray we used,
these genes were not included, we sequenced regions
harbouring the polymorphic sites in the exons 6 and 16
of ATP2A1 [26] and in the exons 3 and 4 of SLC6A5
[23]. Both affected and control samples were mono-
morphic at the examined sites, therefore we can exclude
that BSP in Romagnola was caused by the described mu-
tations leading to CMD1 or CMD2 in Chianina and Bel-
gian Blue breeds.Discussion
The identification of causative genes associated with a
disease is a complex task requiring gathering of genome-
wide information. The assessment of the expression of
thousands of genes simultaneously may pinpoint themetabolic pathways affected by causative mutation(s) in
order to focus on a small set of target genes.
We have tried to assess the metabolic pathways af-
fected by the spastic paresis in Romagnola cattle breed,
which presents this disease at quite a high frequency [2],
using microarrays. The cDNA microarray we used in
this study contains a brain library and, even if carrying
an incomplete transcriptome representation, it has
proven to be a valuable tool allowing us to add useful
and new information to a poorly studied disease. Today,
it is possible to prepare custom microarrays [27], while
direct sequencing of transcripts by high-throughput se-
quencing technologies (RNA-Seq) would probably make
possible to expand microarray investigation. However by
using microarray tool, we analyzed 15 K genes with the
aim to acquire knowledge of a genetic disease for which
the current literature only provides scant results.
Results on metabolic pathways support an alteration of
the Neurodegenerative Diseases and Nervous system C2
classes with the most frequently associated differentially
expressed genes in the BSP (BAD, NEFH, NDUFB2,
DERL1, NEFL). Moreover, the ATP6V0E1 gene, encoding
for a lysosomal H + -transporting ATPase, showed the
strongest signal (FC 81.29) on microarrays and together
with NDUFB2, is involved in intracellular processes and is
linked to Oxidative Phosphorylation pathway. PRKCG is a
member of the protein kinase C (PKC) gene family, whose
members phosphorylate a wide variety of protein targets
and are known to be involved in diverse cellular signalling
pathways. Defects in this protein have been associated with
neurodegenerative disorder spinocerebellar ataxia-14 [28].
Four calcium binding proteins involved in Calcium
Signalling pathway, S100A12, S100A11, S100A8 and
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mals. In Chianina cattle, a missense mutation in exon 6
(c.491G > A) of the bovine ATP2A1/SERCA1 gene, was
implicated in Congenital Pseudomyotonia [24,25], a dis-
ease very similar to BSP and paralleled to human Brody
disease by Drögemüller and collaborators, [26]. The
same gene has been implicated also in Pseudomyotonia in
Dutch Improved Red and White cross-breed [29]. We tested
this mutation in our diseased animals and we did not find
any carrier nevertheless Congenital Pseudomyotonia shares
many symptoms with BSP. Therefore, even if BSP does not
result associated to the mutations causing Congenital
Pseudomyotonia reported in other cattle breeds, our data
suggest the involvement of the calcium signalling proteins
and two C3 classes, the Neurotrophin signalling pathway
and Amyotrophic lateral sclerosis.
Charlier and coll [23] identified a bovine disorder
named CMD2, reminiscent of congenital myoclonus in
Hereford cattle, and reported a mutation in the glycine
transporter GlyT2 (SLC6A5) gene already associated to
human hyperexplexia [30]. Recently, SLC6A5 was also
associated to hyperexplexia in Irish wolfhounds [31].
BSP shows many similarities with human hyperexplexia
(OMIM 149400), an autosomal disease that can be
caused by mutations in the genes encoding the alpha-1
subunit of the glycine receptor (GLRA1), the presynaptic
glycine transporter-2 (SLC6A5), the beta-subunit of the
glycine receptor (GLRB), the postsynaptic glycinergic
proteins GPHN and ARHGEF9 [32-39]. Mutations in the
latter gene cause hyperexplexia with epilepsy (OMIM
300607). In a previous study, we observed a number of
mutations in GLRA1 and GLRB in Romagnola cattle
[40], but none resulted significantly involved in the
disease.
Our microarray results suggest also a defective
glycinergic synaptic transmission in Romagnola BSP.
The expression of the Rho GDP dissociation inhibitor
(GDI) alpha (ARHGDIA) gene, of two neurotransmitter
transporters (SLC41A3 and SLC25A20), of the organic
anion transporter SLCO1A2 resulted altered in affected
animals. In affected samples, we observed the over-
expression of two genes involved in defective glycinergic
synaptic transmission, GRINA and SLC6A9. This latter
gene, encoding GlyT1, was recently implicated in defect-
ive glycinergic synaptic transmission in Zebrafish [41].
GFAP, encoding glial fibrillary acidic protein, linked to
expression of the glutamate transporter Glt1 (SLC1A2)
in Alexander disease, was also over-expressed in affected
animals (FC 2.60). Mutations in NR4A2 (FC 3.06), a nu-
clear receptor family protein, have been associated with
disorders related to dopaminergic dysfunction [42]. Most
transporters involved in the drug disposal, characterized
by broad substrate specificities and accepting structurally
unrelated compounds, include members of SLC family.The involvement of glycinergic proteins seems sup-
ported also at phenotypic level: the cholecystokinin
(CCK) is involved in the neuroactive ligand-receptor
interaction pathway. The release of CCK (ACBP) is
linked to GABA and sensitive to clonazepam [43]. These
features are found also in human hyperexplexia and are
in agreement with the differential expression of some
GABA neurotransmitter transporters of the solute car-
rier family emerging from our analysis.
Conclusions
BSP is a neuromuscular disorder, known since almost a
century, not yet associated with a specific gene. Using
microarrays, we identified several genes and pathways
significantly linked to the development of BSP in
Romagnola cattle breed. We identified genes belonging
to two C3 classes, the Neurotrophin signalling pathway
and the Amyotrophic Lateral Sclerosis.
Our results suggest also that the development of the
disease is linked to a defective glycinergic synaptic
transmission and an alteration of calcium signalling
proteins. We reviewed the literature on the disease in
order to compare published data with the KEGG cat-
egories identified by our microarray analysis. This will
allow a gene targeted analysis aimed to identify BSP-
associated polymorphisms in Romagnola. BSP shares
many symptoms with other nervous diseases in this
and other species, including humans. The study of the
molecular mechanisms underpinning BSP in this and
in other cattle breeds, as well as in other livestock spe-
cies, may help to shed light also on neurodegenerative
human diseases.
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